Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > MYO15A(Gene name) > Human
  • Add your favorite
  • MYO15A (Gene name),
  • Myosin-XV (Protein name ),  MYO15_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    MYO15A(MYO15);
    Protein name:
    Myosin-XV;
    Alternative:
    Unconventional myosin-15;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with the third PDZ domain of WHRN which is necessary for localization of WHRN to stereocilium tips (By similarity). Interacts with FASLG.
    Function:
    Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Required for the arrangement of stereocilia in mature hair bundles.
    Subcellular Location:
    Cell projection stereocilium Cytoplasm cytoskeleton Localizes to stereocilium tips in cochlear and vestibular hair cells.
    Protein Attributes:
    Sequence length:
    3530
    Sequence:
    50:
    MAKEEDEEKK | AKKGKKGKKA | PEPEKPKRSL | KGTSRLFMGF | RDRTPKISKK | 
    100:
    GQFRSASAFF | WGLHTGPQKT | KRKRKARTVL | KSTSKLMTQM | RMGKKKRAMK | 
    150:
    GKKPSFMVIR | FPGRRGYGRL | RPRARSLSKA | STAINWLTKK | FLLKKAEESG | 
    200:
    SEQATVDAWL | QRSSSRMGSR | KLPFPSGAEI | LRPGGRLRRF | PRSRSIYASG | 
    250:
    EPLGFLPFED | EAPFHHSGSR | KSLYGLEGFQ | DLGEYYDYHR | DGDDYYDRQS | 
    300:
    LHRYEEQEPY | LAGLGPYSPA | WPPYGDHYYG | YPPEDPYDYY | HPDYYGGPFD | 
    350:
    PGYTYGYGYD | DYEPPYAPPS | GYSSPYSYHD | GYEGEAHPYG | YYLDPYAPYD | 
    400:
    APYPPYDLPY | HTPYDVPYFD | PYGVHYTVPY | AEGVYGGGDE | AIYPPEVPYF | 
    450:
    YPEESASAFV | YPWVPPPIPS | PHNPYAHAMD | DIAELEEPED | AGVERQGTSF | 
    500:
    RLPSAAFFEQ | QGMDKPARSK | LSLIRKFRLF | PRPQVKLFGK | EKLEVPLPPS | 
    550:
    LDIPLPLGDA | DEEEDEEELP | PVSAVPYGHP | FWGFLTPRQR | NLQRALSAFG | 
    600:
    AHRGLGFGPE | FGRPVPRPAT | SLARFLKKTL | SEKKPIARLR | GSQKARAGGP | 
    650:
    AVREAAYKRF | GYKLAGMDPE | KPGTPIVLRR | AQPRARSSND | ARRPPAPQPA | 
    700:
    PRTLSHWSAL | LSPPVPPRPP | SSGPPPAPPL | SPALSGLPRP | ASPYGSLRRH | 
    750:
    PPPWAAPAHV | PPAPQASWWA | FVEPPAVSPE | VPPDLLAFPG | PRPSFRGSRR | 
    800:
    RGAAFGFPGA | SPRASRRRAW | SPLASPQPSL | RSSPGLGYCS | PLAPPSPQLS | 
    850:
    LRTGPFQPPF | LPPARRPRSL | QESPAPRRAA | GRLGPPGSPL | PGSPRPPSPP | 
    900:
    LGLCHSPRRS | SLNLPSRLPH | TWRRLSEPPT | RAVKPQVRLP | FHRPPRAGAW | 
    950:
    RAPLEHRESP | REPEDSETPW | TVPPLAPSWD | VDMPPTQRPP | SPWPGGAGSR | 
    1000:
    RGFSRPPPVP | ENPFLQLLGP | VPSPTLQPED | PAADMTRVFL | GRHHEPGPGQ | 
    1050:
    LTKSAGPTPE | KPEEEATLGD | PQLPAETKPP | TPAPPKDVTP | PKDITPPKDV | 
    1100:
    LPEQKTLRPS | LSYPLAACDQ | TRATWPPWHR | WGTLPQAAAP | LAPIRAPEPL | 
    1150:
    PKGGERRQAA | PGRFAVVMPR | VQKLSSFQRV | GPATLKPQVQ | PIQDPKPRAC | 
    1200:
    SLRWSCLWLR | ADAYGPWPRV | HTHPQSCHLG | PGAACLSLRG | SWEEVGPPSW | 
    1250:
    RNKMHSIRNL | PSMRFREQHG | EDGVEDMTQL | EDLQETTVLS | NLKIRFERNL | 
    1300:
    IYTYIGSILV | SVNPYQMFGI | YGPEQVQQYN | GRALGENPPH | LFAVANLAFA | 
    1350:
    KMLDAKQNQC | IIISGESGSG | KTEATKLILR | YLAAMNQKRE | VMQQIKILEA | 
    1400:
    TPLLESFGNA | KTVRNDNSSR | FGKFVEIFLE | GGVISGAITS | QYLLEKSRIV | 
    1450:
    FQAKNERNYH | IFYELLAGLP | AQLRQAFSLQ | EAETYYYLNQ | GGNCEIAGKS | 
    1500:
    DADDFRRLLA | AMEVLGFSSE | DQDSIFRILA | SILHLGNVYF | EKYETDAQEV | 
    1550:
    ASVVSAREIQ | AVAELLQISP | EGLQKAITFK | VTETMREKIF | TPLTVESAVD | 
    1600:
    ARDAIAKVLY | ALLFSWLITR | VNALVSPRQD | TLSIAILDIY | GFEDLSFNSF | 
    1650:
    EQLCINYANE | NLQYLFNKIV | FQEEQEEYIR | EQIDWQEITF | ADNQPCINLI | 
    1700:
    SLKPYGILRI | LDDQCCFPQA | TDHTFLQKCH | YHHGANPLYS | KPKMPLPEFT | 
    1750:
    IKHYAGKVTY | QVHKFLDKNH | DQVRQDVLDL | FVRSRTRVVA | HLFSSHAPQA | 
    1800:
    APQRLGKSSS | VTRLYKAHTV | AAKFQQSLLD | LVEKMERCNP | LFMRCLKPNH | 
    1850:
    KKEPGLFEPD | VVMAQLRYSG | VLETVRIRKE | GFPVRLPFQG | FIDRYCCLVA | 
    1900:
    LKHDLPANGD | MCVSVLSRLC | KVMPNMYRVG | VSKLFLKEHL | YQLLESMREH | 
    1950:
    VLNLAALTLQ | RCLRGFFIKR | RFRSLRHKII | LLQSRARGYL | ARQRYQQMRR | 
    2000:
    SLVKFRSLVH | AYVSRRRYLK | LRAEWRCQVE | GALLWEQEEL | SKREVVAVGH | 
    2050:
    LEVPAELAGL | LQAVAGLGLA | QVPQVAPVRT | PRLQAEPRVT | LPLDINNYPM | 
    2100:
    AKFVQCHFKE | PAFGMLTVPL | RTPLTQLPAE | HHAEAVSIFK | LILRFMGDPH | 
    2150:
    LHGARENIFG | NYIVQKGLAV | PELRDEILAQ | LANQVWHNHN | AHNAERGWLL | 
    2200:
    LAACLSGFAP | SPCFNKYLLK | FVSDYGRNGF | QAVCQHRLMQ | AMGRAQQQGS | 
    2250:
    GAARTLPPTQ | LEWTATYEKA | SMALDVGCFN | GDQFSCPVHS | WSTGEEVAGD | 
    2300:
    ILRHRGLADG | WRGWTVAMKN | GVQWAELAGH | DYVLDLVSDL | ELLRDFPRQK | 
    2350:
    SYFIVGTEGP | AASRGGPKVV | FGNSWDSDED | MSTRPQPQEH | MPKVLDSDGY | 
    2400:
    SSHNQDGTNG | ETEAQRGTAT | HQESDSLGEP | AVPHKGLDCY | LDSLFDPVLS | 
    2450:
    YGDADLEKPT | AIAYRMKGGG | QPGGGSSSGT | EDTPRRPPEP | KPIPGLDAST | 
    2500:
    LALQQAFIHK | QAVLLAREMT | LQATALQQQP | LSAALRSLPA | EKPPAPEAQP | 
    2550:
    TSVGTGPPAK | PVLLRATPKP | LAPAPLAKAP | RLPIKPVAAP | VLAQDQASPE | 
    2600:
    TTSPSPELVR | YSTLNSEHFP | QPTQQIKNIV | RQYQQPFRGG | RPEALRKDGG | 
    2650:
    KVFMKRPDPH | EEALMILKGQ | MTHLAAAPGT | QVSREAVALV | KPVTSAPRPS | 
    2700:
    MAPTSALPSR | SLEPPEELTQ | TRLHRLINPN | FYGYQDAPWK | IFLRKEVFYP | 
    2750:
    KDSYSHPVQL | DLLFRQILHD | TLSEACLRIS | EDERLRMKAL | FAQNQLDTQK | 
    2800:
    PLVTESVKRA | VVSTARDTWE | VYFSRIFPAT | GSVGTGVQLL | AVSHVGIKLL | 
    2850:
    RMVKGGQEAG | GQLRVLRAYS | FADILFVTMP | SQNMLEFNLA | SEKVILFSAR | 
    2900:
    AHQVKTLVDD | FILELKKDSD | YVVAVRNFLP | EDPALLAFHK | GDIIHLQPLE | 
    2950:
    PPRVGYSAGC | VVRRKVVYLE | ELRRRGPDFG | WRFGTIHGRV | GRFPSELVQP | 
    3000:
    AAAPDFLQLP | TEPGRGRAAA | VAAAVASAAA | AQEVGRRREG | PPVRARSADH | 
    3050:
    GEDALALPPY | TMLEFAQKYF | RDPQRRPQDG | LRLKSKEPRE | SRTLEDMLCF | 
    3100:
    TKTPLQESLI | ELSDSSLSKM | ATDMFLAVMR | FMGDAPLKGQ | SDLDVLCNLL | 
    3150:
    KLCGDHEVMR | DECYCQVVKQ | ITDNTSSKQD | SCQRGWRLLY | IVTAYHSCSE | 
    3200:
    VLHPHLTRFL | QDVSRTPGLP | FQGIAKACEQ | NLQKTLRFGG | RLELPSSIEL | 
    3250:
    RAMLAGRSSK | RQLFLLPGGL | ERHLKIKTCT | VALDVVEEIC | AEMALTRPEA | 
    3300:
    FNEYVIFVVT | NRGQHVCPLS | RRAYILDVAS | EMEQVDGGYM | LWFRRVLWDQ | 
    3350:
    PLKFENELYV | TMHYNQVLPD | YLKGLFSSVP | ASRPSEQLLQ | QVSKLASLQH | 
    3400:
    RAKDHFYLPS | VREVQEYIPA | QLYRTTAGST | WLNLVSQHRQ | QTQALSPHQA | 
    3450:
    RAQFLGLLSA | LPMFGSSFFF | IQSCSNIAVP | APCILAINHN | GLNFLSTETH | 
    3500:
    ELMVKFPLKE | IQSTRTQRPT | ANSSYPYVEI | ALGDVAAQRT | LQLQLEQGLE | 
    3530:
    LCRVVAVHVE | NLLSAHEKRL | TLPPSEITLL | 
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    String:
    MIM:
    UniGene:
    SMR:
    KEGG:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human Myosin-XV
    ELISA Kit for Human Myosin-XV
    CLIA Kit for Human Myosin-XV
    CLIA Kit for Human Myosin-XV
    Polyclonal Antibody for Human Myosin-XV
    Polyclonal Antibody for Human Myosin-XV
    Monoclonal Antibody for Human Myosin-XV
    Monoclonal Antibody for Human Myosin-XV
    Protein for Human Myosin-XV
    Protein for Human Myosin-XV

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3."
      Wang A. , Liang Y. , Fridell R.A. , Probst F.J. , Wilcox E.R. , Touchman J.W. , Morton C.C. , Morell R.J. , Noben-Trauth K. , Camper S.A. , Friedman T.B.
      Science280:1447-1451(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS DFNB3 TYR-2111 AND PHE-2113
    2. 2.
      "Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2."
      Liang Y. , Wang A. , Belyantseva I.A. , Anderson D.W. , Probst F.J. , Barber T.D. , Miller W. , Touchman J.W. , Jin L. , Sullivan S.L. , Sellers J.R. , Camper S.A. , Lloyd R.V. , Kachar B. , Friedman T.B. , Fridell R.A.
      Genomics61:243-258(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1);TISSUE SPECIFICITY
    3. 3.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)
      tissue: Cerebellum.
    4. 5.
      "Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening."
      Voss M. , Lettau M. , Janssen O.
      BMC Immunol.10:53-53(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH FASLG
    5. 6.
      "Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome."
      Liburd N. , Ghosh M. , Riazuddin S. , Naz S. , Khan S. , Ahmed Z. , Riazuddin S. , Liang Y. , Menon P.S.N. , Smith T. , Smith A.C.M. , Chen K.-S. , Lupski J.R. , Wilcox E.R. , Potocki L. , Friedman T.B.
      Hum. Genet.109:535-541(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT DFNB3 HIS-2716;VARIANT ILE-2205
    6. 7.
      "Whole exome sequencing identifies new causative mutations in Tunisian families with non-syndromic deafness."
      Riahi Z. , Bonnet C. , Zainine R. , Louha M. , Bouyacoub Y. , Laroussi N. , Chargui M. , Kefi R. , Jonard L. , Dorboz I. , Hardelin J.P. , Salah S.B. , Levilliers J. , Weil D. , McElreavey K. , Boespflug O.T. , Besbes G. , Abdelhak S. , more...
      PLoS ONE9:E99797-E99797(2014) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN DFNB3;VARIANT DFNB3 PRO-1806
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter